6% HETASTARCH IN 0.9% SODIUM CHLORIDE
NDC 51662-1317, 6% HETASTARCH IN 0.9% SODIUM CHLORIDE, injection, solution, from HF Acquisition Co LLC, DBA HealthFirst.
- Product NDC
- 51662-1317
- Status
- Listed
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- BA740193
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1317 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HETASTARCH6 g/100mL
Pharmacologic classes
Increased Intravascular Volume [PE]; Osmotic Activity [MoA]; Plasma Volume Expander [EPC]; Starch [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51662-1317-1 | 51662131701 | 500 mL in 1 CONTAINER (51662-1317-1) |
| 51662-1317-3 | 51662131703 | 12 CONTAINER in 1 CASE (51662-1317-3) / 500 mL in 1 CONTAINER (51662-1317-2) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7b97c681-4514-c544-e053-2991aa0a3d78
Use it
Look up 51662-1317 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1317 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51662-1317. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.